10325811000001104: Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Selegiline\Product containing only selegiline in oral dose form (medicinal product form)\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Selegiline\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing monoamine oxidase inhibitor\Product containing monoamine oxidase B inhibitor\Product containing selegiline\Selegiline\Product containing only selegiline in oral dose form (medicinal product form)\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing monoamine oxidase inhibitor\Product containing monoamine oxidase B inhibitor\Product containing selegiline\Selegiline\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing monoamine oxidase inhibitor\Product containing monoamine oxidase B inhibitor\Product containing selegiline\Product containing selegiline in oral dose form (medicinal product form)\Product containing only selegiline in oral dose form (medicinal product form)\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing selegiline\Selegiline\Product containing only selegiline in oral dose form (medicinal product form)\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing selegiline\Selegiline\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing selegiline\Product containing selegiline in oral dose form (medicinal product form)\Product containing only selegiline in oral dose form (medicinal product form)\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing selegiline in oral dose form (medicinal product form)\Product containing only selegiline in oral dose form (medicinal product form)\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing selegiline in oral dose form (medicinal product form)\Product containing only selegiline in oral dose form (medicinal product form)\Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet\Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

35541101000001116 Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

35541201000001111 Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) freeness indicator	Sugar free	true	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Is a	Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Has active ingredient	Selegiline hydrochloride	false	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral lyophilisate	false	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Has specific active ingredient	Selegiline hydrochloride	true	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Has dispensed dose form	Conventional release oral lyophilisate	true	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet	Is pack of	False	Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) 30 tablet	Has AMP	True	Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
35541101000001116	Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
35541201000001111	Selegiline 1.25mg oral lyophilisates sugar free (Focus Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module